Yeshwant Krishna

CIK 00015850014 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001585001

Recent Transactions

50 trades

Award
Parabilis Medicines, Inc.$PBLS
Stock Option (Right to Buy)
2026-06-09+20,215→ 20,215 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−136,139→ 0 total
Disposition from Tender
Verve Therapeutics, Inc.
Common Stock
2025-07-25−4,260,047→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−42,200→ 0 total
Disposition from Tender
Verve Therapeutics, Inc.
Common Stock
2025-07-25−6,108,442→ 0 total
Disposition from Tender
Verve Therapeutics, Inc.
Common Stock
2025-07-25−1,800,000→ 0 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-06-05+42,200→ 42,200 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2024-06-26+136,139→ 136,139 total
Purchase
Verve Therapeutics, Inc.
Common Stock
2023-12-01$10.00/sh+1,800,000→ 1,800,000 total
Disposition to Issuer
EQRx, Inc.
Stock Option (Right to Buy)
2023-11-09−101,010→ 0 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2023-06-15+26,642→ 26,642 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-04$31.99/sh−650→ 4,260,290 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-04$32.90/sh−243→ 4,260,047 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-04$31.12/sh−47,690→ 4,260,940 total
Other
Verve Therapeutics, Inc.
Common Stock
2022-11-04−48,583→ 6,108,442 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-03$33.84/sh−1,755→ 4,308,630 total
Other
Verve Therapeutics, Inc.
Common Stock
2022-11-03−49,569→ 6,157,025 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-03$32.32/sh−22,279→ 4,335,919 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-03$33.14/sh−25,534→ 4,310,385 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-02$36.77/sh−8,930→ 4,358,198 total
Other
Verve Therapeutics, Inc.
Common Stock
2022-11-02−28,651→ 6,206,594 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-02$34.78/sh−9,350→ 4,377,500 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-02$36.28/sh−10,372→ 4,367,128 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-01$37.82/sh−2,377→ 4,387,110 total
Other
Verve Therapeutics, Inc.
Common Stock
2022-11-01−31,963→ 6,235,245 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-01$38.64/sh−260→ 4,386,850 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-01$36.69/sh−29,326→ 4,389,487 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-10-31$38.94/sh−23,275→ 4,425,502 total
Other
Verve Therapeutics, Inc.
Common Stock
2022-10-31−53,697→ 6,267,208 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-10-31$40.64/sh−88→ 4,418,813 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-10-31$37.91/sh−23,732→ 4,448,777 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-10-31$40.16/sh−6,601→ 4,418,901 total
Award
EQRx, Inc.
Stock Option (Right to Buy)
2022-09-30+101,010→ 101,010 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-06-09+15,500→ 15,500 total
Conversion
Verve Therapeutics, Inc.
Common Stock
2021-06-21+4,029,244→ 4,029,244 total
Conversion
Verve Therapeutics, Inc.
Series A-2 Preferred Stock
2021-06-21−37,308,792→ 0 total
Conversion
Verve Therapeutics, Inc.
Series A Preferred Stock
2021-06-21−58,528,428→ 0 total
Conversion
Verve Therapeutics, Inc.
Series B Preferred Stock
2021-06-21−4,104,416→ 0 total
Conversion
Verve Therapeutics, Inc.
Common Stock
2021-06-21+6,320,905→ 6,320,905 total
Conversion
Verve Therapeutics, Inc.
Common Stock
2021-06-21+443,265→ 4,472,509 total
Disposition from Tender
Foundation Medicine, Inc.
Common Stock
2018-07-31$137.00/sh−5,786→ 0 total
Sale
Foundation Medicine, Inc.
Common Stock
2017-08-08$40.01/sh−4,800→ 5,786 total
Exercise/Conversion
Foundation Medicine, Inc.
Common Stock
2017-08-04−13,385→ 0 total
Tax Payment
Foundation Medicine, Inc.
Common Stock
2017-08-04$37.75/sh−8,585→ 10,586 total
Exercise/Conversion
Foundation Medicine, Inc.
Common Stock
2017-08-04$24.21/sh+13,385→ 19,171 total
Sale
Foundation Medicine, Inc.
Common Stock
2017-08-04$36.85/sh−18,072→ 5,786 total
Award
Foundation Medicine, Inc.
Common Stock
2017-06-20$40.05/sh+5,786→ 23,858 total
Award
Foundation Medicine, Inc.
Common Stock
2016-06-16$19.93/sh+12,075→ 18,072 total
Award
Foundation Medicine, Inc.
Common Stock
2015-06-18$32.23/sh+5,997→ 5,997 total
Sale
Foundation Medicine, Inc.
Common Stock
2015-06-15$32.33/sh−114,481→ 0 total

Companies

Recent Filings

Address

C/O PARABILIS MEDICINES, INC. 30 ACORN PARK DRIVE, 6TH FLOOR

CAMBRIDGE, MA, 02140

View on SEC.gov